← Leaderboards
Bakhos A. Tannous
Massachusetts General Hospital
$11,831,527
Attributed
$13,621,263
Total exposure
17
Grants
13
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.5M · FY2007–22$2.5M$1.9M$1.3M$625K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$16,399,461 · 18
By mechanism
R01$6,824,172 · 4
P30$5,486,796 · 5
R21$2,654,175 · 6
R00$731,628 · 1
R61$420,000 · 1
K99$282,690 · 1
Top collaborators
- Xandra Owens Breakefield20 shared
- Christian Elias Badr1 shared
- Norman H. L. Chiu1 shared
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Xandra Owens Breakefield$30,735,276
- Christopher Irwin Moore$9,205,090
- E. Antonio Chiocca$34,514,665
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsTumorGliomaBaseMonitorMolecularIn VivoBrainGlioblastomaMalignant - DescriptorNeoplastic CellAreaSurvival RateCentral Nervous System NeoplasmsRadiationOperative Surgical ProceduresResistancePharmaceutical PreparationsBrain NeoplasmsRecurrenceValidationLuciferasesExcisionDose
Grant awards (54)
Immuno-cell therapy for brain tumors$614,898
R01 · FY2022 · NS · contact PI
Radiation-induced targeted extracellular vesicles -based gene delivery for glioma therapy$206,600
R21 · FY2021 · NS · contact PI
Novel diffuse intrinsic pontine glioma therapy$455,200
R21 · FY2020 · NS · contact PI
Epitranscriptome Associated with Glioblastoma Therapeutic Resistance$450,875
R21 · FY2020 · NS · contact PI
Screening for DNA damage response modulators in glioblastoma stem cells$420,000
R61 · FY2020 · NS · contact PI
Radiation-induced targeted extracellular vesicles -based gene delivery for glioma therapy$248,600
R21 · FY2020 · NS · contact PI
Glioblastoma stem cells therapy$388,606
R01 · FY2019 · NS · contact PI
Interdepartmental Neuroscience Center$696,000
P30 · FY2018 · NS
Glioblastoma stem cells therapy$476,385
R01 · FY2018 · NS · contact PI
Screening for adjuvant gliobalstoma therapeutics$374,063
R01 · FY2018 · NS · contact PI
Core C Interdepartmental Neuroscience Center$208,005
P30 · FY2018 · NS
Core A Interdepartmental Neuroscience Center$175,478
P30 · FY2018 · NS
Core B Interdepartmental Neuroscience Center$175,230
P30 · FY2018 · NS
Admin Core Interdepartmental Neuroscience Center$67,687
P30 · FY2018 · NS
Interdepartmental Neuroscience Center$696,000
P30 · FY2017 · NS
Glioblastoma stem cells therapy$476,385
R01 · FY2017 · NS · contact PI
Screening for adjuvant gliobalstoma therapeutics$374,063
R01 · FY2017 · NS · contact PI
Core C Interdepartmental Neuroscience Center$237,463
P30 · FY2017 · NS
Core A Interdepartmental Neuroscience Center$197,308
P30 · FY2017 · NS
Core B Interdepartmental Neuroscience Center$197,001
P30 · FY2017 · NS
Admin Core Interdepartmental Neuroscience Center$64,228
P30 · FY2017 · NS
Interdepartmental Neuroscience Center$696,000
P30 · FY2016 · NS
Glioblastoma stem cells therapy$380,625
R01 · FY2016 · NS · contact PI
Screening for adjuvant gliobalstoma therapeutics$374,063
R01 · FY2016 · NS · contact PI
Core C Interdepartmental Neuroscience Center$225,404
P30 · FY2016 · NS
Blood-based assays for the detection of glioblastoma RNA biomarkers$217,500
R21 · FY2016 · NS · contact PI
Core A Interdepartmental Neuroscience Center$192,880
P30 · FY2016 · NS
Core B Interdepartmental Neuroscience Center$192,632
P30 · FY2016 · NS
Glioblastoma stem cells therapy$87,779
R01 · FY2016 · NS · contact PI
Admin Core Interdepartmental Neuroscience Center$85,084
P30 · FY2016 · NS
Interdepartmental Neuroscience Center$690,198
P30 · FY2015 · NS
Glioblastoma stem cells therapy$361,200
R01 · FY2015 · NS · contact PI
Screening for modulators of glioma stem cells differentiation$357,979
R01 · FY2015 · CA · contact PI
Blood-based assays for the detection of glioblastoma RNA biomarkers$261,000
R21 · FY2015 · NS · contact PI
Core C Interdepartmental Neuroscience Center$217,474
P30 · FY2015 · NS
Core A Interdepartmental Neuroscience Center$202,817
P30 · FY2015 · NS
Core B Interdepartmental Neuroscience Center$194,701
P30 · FY2015 · NS
Admin Core Interdepartmental Neuroscience Center$75,206
P30 · FY2015 · NS
Screening for modulators of glioma stem cells differentiation$347,240
R01 · FY2014 · CA · contact PI
Detection of NSCLC-derived mutant RNA in platelets$183,549
R21 · FY2014 · CA · contact PI
Glioblastoma stem cells therapy$366,163
R01 · FY2013 · NS · contact PI
Screening for modulators of glioma stem cells differentiation$339,553
R01 · FY2013 · CA · contact PI
Detection of NSCLC-derived mutant RNA in platelets$207,756
R21 · FY2013 · CA · contact PI
Glioblastoma stem cells therapy$379,444
R01 · FY2012 · NS · contact PI
Glioblastoma stem cells therapy$379,444
R01 · FY2011 · NS · contact PI
Imaging and therapy of tumors using biotinylated cell surface docking sites$237,345
R00 · FY2011 · CA · contact PI
Glioblastoma stem cells therapy$379,981
R01 · FY2010 · NS · contact PI
Imaging and therapy of tumors using biotinylated cell surface docking sites$245,284
R00 · FY2010 · CA · contact PI
High throughput bioluminescence screening for glioma therapeutics$191,657
R21 · FY2010 · NS · contact PI
Glioblastoma stem cells therapy$366,301
R01 · FY2009 · NS · contact PI
Imaging and therapy of tumors using biotinylated cell surface docking sites$248,999
R00 · FY2009 · CA · contact PI
High throughput bioluminescence screening for glioma therapeutics$231,438
R21 · FY2009 · NS · contact PI
Imaging and therapy of tumors using biotinylated cell surface docking sites$141,750
K99 · FY2008 · CA · contact PI
Imaging and therapy of tumors using biotinylated cell surface docking sites$140,940
K99 · FY2007 · CA · contact PI